Screening for novel, stage-specific inhibitors of herpes simplex virus replication

Screening for novel, stage-specific inhibitors of herpes simplex virus replication

About
Herpes simplex virus (HSV) is a clinically significant human pathogen. Early stages of the HSV replication cycle, between attachment and gene expression, are poorly understood compared to later steps such as DNA replication. These early events in viral replication include entry into cells, trafficking to the nucleus, uncoating, and expression of viral genes. Small molecule inhibitors have historically played a major role in elucidating the underlying biology of viruses in their uninhibited states. Therefore, we hypothesized that we could learn more about early steps by identifying novel stage-specific inhibitors of HSV replication. We designed a chemical screening approach to identify small molecules that inhibit HSV replication prior to viral DNA replication. We infected Vero cells with ICP8-GFP, a recombinant HSV that expresses green fluorescent protein (GFP) fused to an HSV early protein, ICP8. Expression of ICP8 is among the last events to occur prior to replication of the viral genome, and the GFP reporter would only be expressed if the prior events occurred successfully. Our screen identified ouabain, a cardiac glycoside. Ouabain decreased viral yield by 100-fold without affecting cellular metabolic activity in an overnight assay. We performed kinetic assays and determined that ouabain did not inhibit viral attachment, viral entry, or transcription of viral immediate early mRNA's. Ouabain did inhibit accumulation of viral IE proteins, and labeling of both cellular and viral proteins in a 35-S methionine assay. Protein stability was not decreased in a pulse-chase assay. Collectively, these data indicate that ouabain has a global effect on translation. To better understand the mechanism of ouabain's antiviral activity, we performed a structure activity relationship assay, and determined that the antiviral potencies of other cardiac glycosides correlated with their potencies against the known target of these compounds, the cellular sodium potassium ATPase. We also determined that inhibition was time-dependent and reversible with removal of drug. Treatment with excess potassium chloride partially alleviated the antiviral effect of ouabain, suggesting that ouabain's effect on translation is due to an effect on cellular potassium.

Discuss Screening for novel, stage-specific inhibitors of herpes simplex virus replication with other readers

Join or start a book club for Screening for novel, stage-specific inhibitors of herpes simplex virus replication on Readfeed. Live chat, shared reading progress, and AI discussion questions — free to get started.

Frequently asked questions

How do I join a book club for Screening for novel, stage-specific inhibitors of herpes simplex virus replication?

Sign up free on Readfeed, then browse public clubs or start your own club with Screening for novel, stage-specific inhibitors of herpes simplex virus replication as the current read. Invite friends with a share link and discuss together with live chat and AI discussion questions.

Can I discuss Screening for novel, stage-specific inhibitors of herpes simplex virus replication with other readers online?

Yes. Readfeed book clubs let you chat live, share progress, and join discussions about Screening for novel, stage-specific inhibitors of herpes simplex virus replication with readers worldwide — whether your club is virtual, in-person, or hybrid.

Is Readfeed free?

Yes. Creating an account and joining book clubs is free. Sign up to find readers who love the same books and start discussing today.